← back to search

Jonathan Serrano

New York University · US
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Biology, DNA methylation, Methylation, Cancer research, Classifier (UML), and Sarcoma.
h-index
citations
4,979
works
26
NIH funding
primary concept
email

Recent publications

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
Cancer Cell 2025cited by 14position: middledoi
Metabolic profiling of adult and pediatric gliomas reveals enriched glucose availability in pediatric gliomas and increased fatty acid oxidation in adult gliomas
Acta Neuropathologica Communications 2025cited by 9position: middledoi
DNA methylation profiling of pituitary neuroendocrine tumors identifies distinct clinical and pathological subtypes based on epigenetic differentiation
Neuro-Oncology 2025cited by 8position: middledoi
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
medRxiv 2025cited by 5position: middledoi
Advancing sarcoma diagnostics with expanded DNA methylation-based classification
medRxiv 2025cited by 3position: middledoi
Prognostic value of DNA methylation subclassification, aneuploidy, and <i>CDKN2A/B</i> homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas
Neuro-Oncology 2024cited by 12position: middledoi
Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA
Cancer Discovery 2023cited by 88position: middledoi
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors—A prospective study and guidelines for clinical testing
Neuro-Oncology Advances 2023cited by 33position: middledoi
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
Nature Cancer 2022cited by 47position: middledoi
DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
Clinical Cancer Research 2022cited by 31position: middledoi
Sarcoma classification by DNA methylation profiling
Nature Communications 2021cited by 536position: middledoi
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
Research Square 2021cited by 6position: middledoi
Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
eLife 2020cited by 155position: middledoi
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma
Cancer Research 2020cited by 62position: middledoi
Primary CNS Alveolar Rhabdomyosarcoma: Importance of Epigenetic and Transcriptomic Assays for Accurate Diagnosis
Journal of Neuropathology & Experimental Neurology 2019cited by 13position: middledoi
DNA methylation-based classification of central nervous system tumours
Nature 2018cited by 3,091position: middledoi
Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations
Acta Neuropathologica 2018cited by 139position: middledoi
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma
Nature Communications 2018cited by 78position: middledoi
Whole Genome DNA Methylation Analysis of Human Glioblastoma Using Illumina BeadArrays
Methods in molecular biology 2018cited by 54position: firstdoi
EMBR-02. RECURRENT HOMOZYGOUS DELETION OF DROSHA AND MICRODUPLICATION OF PDE4DIP CONTAINING THE ANCESTRAL DUF1220 DOMAIN IN PINEOBLASTOMA
Neuro-Oncology 2018cited by 0position: middledoi
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2
Cell Reports 2017cited by 128position: middledoi
Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells
Oncotarget 2017cited by 76position: middledoi
Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway
Acta Neuropathologica 2016cited by 259position: middledoi
<i>IDH2</i> Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity
Cancer Research 2016cited by 132position: middledoi
Abstract 11: Advancing methylation profiling in neuropathology: Diagnosis and clinical management
Clinical Cancer Research 2016cited by 0position: middledoi
TB-27SUBGROUP-SPECIFIC OUTCOMES OF CHILDREN WITH MALIGNANT CHILDHOOD BRAIN TUMORS TREATED WITH AN IRRADIATION-SPARING PROTOCOL
Neuro-Oncology 2016cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matija Snuderl · NYU Langone Health10 papers (2016–2025)Aristotelis Tsirigos · NYU Langone Health4 papers (2016–2022)David Jones · Mayo Clinic in Florida4 papers (2016–2019)Varshini Vasudevaraja · NYU Langone Health4 papers (2020–2025)Jeffrey C. Allen · National Laboratory of the Rockies3 papers (2016–2019)Cheddhi Thomas · New York University3 papers (2016–2016)Matthias A. Karajannis · New York Proton Center3 papers (2016–2016)Andreas von Deimling · Stiftung Schleswig-Holsteinische Landesmuseen2 papers (2016–2019)Joshua D. Frenster · New York University2 papers (2017–2020)Dimitris G. Placantonakis · NYU Langone Health2 papers (2017–2020)Volker Hovestadt · Harvard University2 papers (2016–2016)Michael DeLorenzo · New York University2 papers (2020–2022)David Zagzag · New York University2 papers (2016–2017)John G. Golfinos · New York University2 papers (2017–2025)Adriana Heguy · New York Genome Center2 papers (2016–2017)Sharon L. Gardner · New York University2 papers (2016–2016)David Capper · German Cancer Research Center2 papers (2016–2016)Stefan M. Pfister · Université du Québec2 papers (2016–2016)Luis Chiriboga · New York University1 papers (2017–2017)Lukas Chávez · Children’s Institute1 papers (2016–2016)